Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Charlotte Ariyan"'
Autor:
Michael R. Cassidy, Rachel E. Wolchok, Junting Zheng, Katherine S. Panageas, Jedd D. Wolchok, Daniel Coit, Michael A. Postow, Charlotte Ariyan
Publikováno v:
EBioMedicine, Vol 18, Iss C, Pp 56-61 (2017)
Background: Ipilimumab (IPI) and BRAF inhibitors (BRAFi) improve survival in melanoma, but not all patients will benefit and toxicity can be significant. Pretreatment neutrophil to lymphocyte ratio (NLR) has been associated with outcome in IPI-treate
Externí odkaz:
https://doaj.org/article/ed9d10533b9a446f986d144b1cde317f
Autor:
Matthew C Perez, Jonathan S Zager, Thomas Amatruda, Robert Conry, Charlotte Ariyan, Anupam Desai, John M Kirkwood, Sheryl Treichel, David Cohan, Leon Raskin
Publikováno v:
Melanoma Management, Vol 6, Iss 2 (2019)
Aim: Talimogene laherparepvec (T-VEC) is an intralesional treatment for unresectable cutaneous, subcutaneous and nodal melanoma. COSMUS-1 was conducted to examine how T-VEC is used in US clinical practice. Materials & methods: A chart review was cond
Externí odkaz:
https://doaj.org/article/c8385458321f4b77a503e93ba40e9715
Autor:
Alexander C J, van Akkooi, Tina J, Hieken, Elizabeth M, Burton, Charlotte, Ariyan, Paolo A, Ascierto, Salvatore V M A, Asero, Christian U, Blank, Matthew S, Block, Genevieve M, Boland, Corrado, Caraco, Sydney, Chng, B Scott, Davidson, Joao Pedreira, Duprat Neto, Mark B, Faries, Jeffrey E, Gershenwald, Dirk J, Grunhagen, David E, Gyorki, Dale, Han, Andrew J, Hayes, Winan J, van Houdt, Giorgos C, Karakousis, Willem M C, Klop, Georgina V, Long, Michael C, Lowe, Alexander M, Menzies, Roger, Olofsson Bagge, Thomas E, Pennington, Piotr, Rutkowski, Robyn P M, Saw, Richard A, Scolyer, Kerwin F, Shannon, Vernon K, Sondak, Hussein, Tawbi, Alessandro A E, Testori, Mike T, Tetzlaff, John F, Thompson, Jonathan S, Zager, Charlotte L, Zuur, Jennifer A, Wargo, Andrew J, Spillane, Merrick I, Ross
Publikováno v:
Annals of Surgical Oncology, 29(6), 3694-3708. Springer New York
Exciting advances in melanoma systemic therapies have presented the opportunity for surgical oncologists and their multidisciplinary colleagues to test the neoadjuvant systemic treatment approach in high-risk, resectable metastatic melanomas. Here we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9e872abd5d1a96ea257aff63c3b671c
https://doi.org/10.1245/s10434-021-11236-y
https://doi.org/10.1245/s10434-021-11236-y
Autor:
Jedd D. Wolchok, Maria Jure-Kunkel, Taha Merghoub, Neal Rosen, Jon M. Wigginton, Ashok Gupta, Jianda Yuan, Shachi Vyas, Ruth Ann Gordon, Valerie Russell, Shigehisa Kitano, Jessica Katz, Charlotte Ariyan, Christine A. Pratilas, Gregg Masters, Margaret K. Callahan
PDF file - 528K, Supplementary Figure 1. BMS908662 enhances human T cell activation in vitro in a concentration-dependent manner. Supplementary Figure 2. BMS908662 inhibits the growth of BRAF mutant tumor cells in vitro. Supplementary Figure 3. BMS90
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65d397f69a2a94ebf9bc0580eab85d3d
https://doi.org/10.1158/2326-6066.22537045.v1
https://doi.org/10.1158/2326-6066.22537045.v1
Autor:
Jedd D. Wolchok, Maria Jure-Kunkel, Taha Merghoub, Neal Rosen, Jon M. Wigginton, Ashok Gupta, Jianda Yuan, Shachi Vyas, Ruth Ann Gordon, Valerie Russell, Shigehisa Kitano, Jessica Katz, Charlotte Ariyan, Christine A. Pratilas, Gregg Masters, Margaret K. Callahan
RAF inhibitors selectively block extracellular signal–regulated kinase (ERK) signaling in BRAF-mutant melanomas and have defined a genotype-guided approach to care for this disease. RAF inhibitors have the opposite effect in BRAF wild-type tumor ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::347b0e505ed4a077c0e94936117300de
https://doi.org/10.1158/2326-6066.c.6548308.v1
https://doi.org/10.1158/2326-6066.c.6548308.v1
Autor:
Rodabe N. Amaria, Michael Postow, Elizabeth M. Burton, Michael T. Tetzlaff, Merrick I. Ross, Carlos Torres-Cabala, Isabella C. Glitza, Fei Duan, Denái R. Milton, Klaus Busam, Lauren Simpson, Jennifer L. McQuade, Michael K. Wong, Jeffrey E. Gershenwald, Jeffrey E. Lee, Ryan P. Goepfert, Emily Z. Keung, Sarah B. Fisher, Allison Betof-Warner, Alexander N. Shoushtari, Margaret Callahan, Daniel Coit, Edmund K. Bartlett, Danielle Bello, Parisa Momtaz, Courtney Nicholas, Aidi Gu, Xuejun Zhang, Brinda Rao Korivi, Madhavi Patnana, Sapna P. Patel, Adi Diab, Anthony Lucci, Victor G. Prieto, Michael A. Davies, James P. Allison, Padmanee Sharma, Jennifer A. Wargo, Charlotte Ariyan, Hussein A. Tawbi
Publikováno v:
Nature. 615:E23-E23
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::83f319d9a50b41e86331c6e2f7f9fb7c
https://doi.org/10.1038/s41586-023-05892-1
https://doi.org/10.1038/s41586-023-05892-1
Autor:
Rodabe N. Amaria, Michael Postow, Elizabeth M. Burton, Michael T. Tetzlaff, Merrick I. Ross, Carlos Torres-Cabala, Isabella C. Glitza, Fei Duan, Denái R. Milton, Klaus Busam, Lauren Simpson, Jennifer L. McQuade, Michael K. Wong, Jeffrey E. Gershenwald, Jeffrey E. Lee, Ryan P. Goepfert, Emily Z. Keung, Sarah B. Fisher, Allison Betof-Warner, Alexander N. Shoushtari, Margaret Callahan, Daniel Coit, Edmund K. Bartlett, Danielle Bello, Parisa Momtaz, Courtney Nicholas, Aidi Gu, Xuejun Zhang, Brinda Rao Korivi, Madhavi Patnana, Sapna P. Patel, Adi Diab, Anthony Lucci, Victor G. Prieto, Michael A. Davies, James P. Allison, Padmanee Sharma, Jennifer A. Wargo, Charlotte Ariyan, Hussein A. Tawbi
Publikováno v:
Nature. 611(7934)
Relatlimab and nivolumab combination immunotherapy improves progression-free survival over nivolumab monotherapy in patients with unresectable advanced melanoma1. We investigated this regimen in patients with resectable clinical stage III or oligomet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b26a9b384bdccb31911d9969a80e3b1
https://pubmed.ncbi.nlm.nih.gov/36289334
https://pubmed.ncbi.nlm.nih.gov/36289334
Autor:
Jennifer Wargo, Miles Andrews, Connie Duong, Vancheswaran Gopalakrishnan, Valerio Iebba, Wei-Shen Chen, Lisa Derosa, Bertrand Routy, Gladys Ferrere, Aurélie Fluckiger, Maria Roberti, Paule Opolon, Whijae Roh, Christine Spencer, Irina Fernandez Curbelo, Luis Vence, Alexandre Reuben, Zachary Cooper, Peter Prieto, M. A. Wadud Khan, Alexander Lazar, Michael Tetzlaff, Courtney Hudgens, Pierre-Olivier Gaudreau, Luigi Nezi, Didier Raoult, Lauren Haydu, Hussein Tawbi, Patrick Hwu, Wen-Jen Hwu, Rodabe Amaria, Elizabeth Burton, Scott Woodman, Adi Diab, Sapna Patel, Isabella Glitza, Jianhua Zhang, Nadim Ajami, Joseph Petrosino, Robert Jenq, Michael Davies, Jeffrey Gershenwald, Padmanee Sharma, James Allison, Andrew Futreal, Laurence Zitvogel, Maryam TIDJANI ALOU, Satoru Yonekura, Alexandria Cogdill, Reetakshi Arora, Latasha Little, Curtis Gumbs, Khalida Wani, Margaret Callahan, Mathew Adamow, Michael Postow, Charlotte Ariyan, Julie Gardner, Jennifer McQuade, Michael Wong, Li Zhao
Treatment with combined immune checkpoint blockade (CICB) targeting CTLA-4 and PD-1 is associated with clinical benefit across tumor types, but a high rate of immune-related adverse events (irAE). Insights into biomarkers and mechanisms of response a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::24dcf02e4ee91c54a0239c73fe7cba34
https://doi.org/10.21203/rs.3.rs-119925/v1
https://doi.org/10.21203/rs.3.rs-119925/v1
Publikováno v:
New England Journal of Medicine. 377:2503-2504
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e8c5a2220666b7c0fd2e5d097cf780b
https://doi.org/10.1056/nejmc1714339
https://doi.org/10.1056/nejmc1714339
Autor:
Kitt Falk Petersen, Elif Arioglu Oral, Sylvie Dufour, Douglas Befroy, Charlotte Ariyan, Chunli Yu, Gary W. Cline, Alex M. DePaoli, Simeon I. Taylor, Phillip Gorden, Gerald I. Shulman
Publikováno v:
Journal of Clinical Investigation. 109:1345-1350
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd3eef6f50b0f6ee915368f8ac6a9405
https://doi.org/10.1172/jci0215001
https://doi.org/10.1172/jci0215001